Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1963 4
1964 4
1965 7
1966 9
1967 8
1968 10
1969 25
1970 50
1971 84
1972 77
1973 51
1974 53
1975 78
1976 68
1977 71
1978 67
1979 54
1980 70
1981 73
1982 80
1983 71
1984 141
1985 135
1986 160
1987 197
1988 190
1989 189
1990 305
1991 281
1992 329
1993 396
1994 356
1995 395
1996 415
1997 510
1998 488
1999 572
2000 709
2001 688
2002 766
2003 883
2004 928
2005 941
2006 1065
2007 1116
2008 1189
2009 1242
2010 1279
2011 1270
2012 1293
2013 1357
2014 1405
2015 1401
2016 1437
2017 1428
2018 1467
2019 1400
2020 1474
2021 1468
2022 1350
2023 1319
2024 627
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

31,988 results

Results by year

Filters applied: . Clear all
Page 1
The diagnosis of Parkinson's disease.
Tolosa E, Wenning G, Poewe W. Tolosa E, et al. Lancet Neurol. 2006 Jan;5(1):75-86. doi: 10.1016/S1474-4422(05)70285-4. Lancet Neurol. 2006. PMID: 16361025 Review.
The correct diagnosis of Parkinson's disease is important for prognostic and therapeutic reasons and is essential for clinical research. Investigations of the diagnostic accuracy for the disease and other forms of parkinsonism in community-based …
The correct diagnosis of Parkinson's disease is important for prognostic and therapeutic reasons and is essential for c …
Genetics of Parkinson's disease and related disorders.
Zhang PL, Chen Y, Zhang CH, Wang YX, Fernandez-Funez P. Zhang PL, et al. J Med Genet. 2018 Feb;55(2):73-80. doi: 10.1136/jmedgenet-2017-105047. Epub 2017 Nov 18. J Med Genet. 2018. PMID: 29151060 Review.
Parkinson's disease (PD) is a complex and heterogeneous neurological condition characterised mainly by bradykinesia, resting tremor, rigidity and postural instability, symptoms that together comprise the parkinsonian syndrome. ...Although overall di …
Parkinson's disease (PD) is a complex and heterogeneous neurological condition characterised mainly by bradykinesia, re …
Dopamine transporter SPECT imaging in Parkinson's disease and parkinsonian disorders.
Akdemir ÜÖ, Bora Tokçaer A, Atay LÖ. Akdemir ÜÖ, et al. Turk J Med Sci. 2021 Apr 30;51(2):400-410. doi: 10.3906/sag-2008-253. Turk J Med Sci. 2021. PMID: 33237660 Free PMC article. Review.
The dopamine transporter (DAT) imaging provides an objective tool for the assessment of dopaminergic function of presynaptic terminals which is valuable for the differential diagnosis of parkinsonian disorders related to a striatal dopaminergic deficiency fro …
The dopamine transporter (DAT) imaging provides an objective tool for the assessment of dopaminergic function of presynaptic terminal …
Brain-First versus Gut-First Parkinson's Disease: A Hypothesis.
Borghammer P, Van Den Berge N. Borghammer P, et al. J Parkinsons Dis. 2019;9(s2):S281-S295. doi: 10.3233/JPD-191721. J Parkinsons Dis. 2019. PMID: 31498132 Free PMC article. Review.
Parkinson's disease (PD) is a highly heterogeneous disorder, which probably consists of multiple subtypes. ...
Parkinson's disease (PD) is a highly heterogeneous disorder, which probably consists of multiple subtypes. ...
Differentiating drug-induced parkinsonism from Parkinson's disease: an update on non-motor symptoms and investigations.
Brigo F, Erro R, Marangi A, Bhatia K, Tinazzi M. Brigo F, et al. Parkinsonism Relat Disord. 2014 Aug;20(8):808-14. doi: 10.1016/j.parkreldis.2014.05.011. Epub 2014 Jun 3. Parkinsonism Relat Disord. 2014. PMID: 24935237 Free article. Review.
Drug-induced parkinsonism is the second most common cause of parkinsonism after Parkinson's disease and their distinction has crucial implications in terms of management and prognosis. ...Imaging of the dopaminergic pathway seems to be the only, …
Drug-induced parkinsonism is the second most common cause of parkinsonism after Parkinson's disease and t …
Translational molecular imaging and drug development in Parkinson's disease.
Haider A, Elghazawy NH, Dawoud A, Gebhard C, Wichmann T, Sippl W, Hoener M, Arenas E, Liang SH. Haider A, et al. Mol Neurodegener. 2023 Feb 10;18(1):11. doi: 10.1186/s13024-023-00600-z. Mol Neurodegener. 2023. PMID: 36759912 Free PMC article. Review.
Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects elderly people and constitutes a major source of disability worldwide. ...Further, we will shed light on potential future trends, thereby focusing on potential novel d …
Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects elderly people and constitu …
The history of dopamine and levodopa in the treatment of Parkinson's disease.
Fahn S. Fahn S. Mov Disord. 2008;23 Suppl 3:S497-508. doi: 10.1002/mds.22028. Mov Disord. 2008. PMID: 18781671 Review.
The discoveries of dopamine as a neurotransmitter in the brain, its depletion in patients with Parkinson disease, and its replacement with levodopa therapy were major revolutionary events in the rise to effective therapy for patients with this disorder. This …
The discoveries of dopamine as a neurotransmitter in the brain, its depletion in patients with Parkinson disease, and i …
Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases.
Cai R, Zhang Y, Simmering JE, Schultz JL, Li Y, Fernandez-Carasa I, Consiglio A, Raya A, Polgreen PM, Narayanan NS, Yuan Y, Chen Z, Su W, Han Y, Zhao C, Gao L, Ji X, Welsh MJ, Liu L. Cai R, et al. J Clin Invest. 2019 Oct 1;129(10):4539-4549. doi: 10.1172/JCI129987. J Clin Invest. 2019. PMID: 31524631 Free PMC article.
Parkinson's disease (PD) is a common neurodegenerative disease that lacks therapies to prevent progressive neurodegeneration. ...We found slower disease progression, decreased PD-related complications, and a reduced frequency of PD diagnoses in …
Parkinson's disease (PD) is a common neurodegenerative disease that lacks therapies to prevent progressive neuro …
Nigrostriatal tau pathology in parkinsonism and Parkinson's disease.
Chu Y, Hirst WD, Federoff HJ, Harms AS, Stoessl AJ, Kordower JH. Chu Y, et al. Brain. 2024 Feb 1;147(2):444-457. doi: 10.1093/brain/awad388. Brain. 2024. PMID: 38006313 Free PMC article.
While Parkinson's disease remains clinically defined by cardinal motor symptoms resulting from nigrostriatal degeneration, it is now appreciated that the disease commonly consists of multiple pathologies, but it is unclear where these co-pathologies oc …
While Parkinson's disease remains clinically defined by cardinal motor symptoms resulting from nigrostriatal degenerati …
[Parkinson's disease].
Warnecke T, Lummer C, Rey JW, Claus I, Lüttje D. Warnecke T, et al. Inn Med (Heidelb). 2023 Feb;64(2):131-138. doi: 10.1007/s00108-022-01444-3. Epub 2022 Dec 8. Inn Med (Heidelb). 2023. PMID: 36480073 Review. German.
Parkinson's disease (PD) is an unparalleled example of a neurodegenerative disorder that can be effectively managed leading to sustained symptom control and quality of life. The cooperation of neurologists with general practitioners, gastroenterologists, and …
Parkinson's disease (PD) is an unparalleled example of a neurodegenerative disorder that can be effectively managed lea …
31,988 results
You have reached the last available page of results. Please see the User Guide for more information.